Breaking News: Baxter International's North Carolina Facility Closure due to Hurricane Helene Could Impact IV Fluid Supply Chain, FDA Warns of Shortages
In a recent development, Baxter International's North Cove facility in North Carolina has been forced to shut down following the devastation caused by Hurricane Helene. This closure could potentially lead to a shortage in intravenous fluids, according to a statement by the U.S. Department of Health and Human Services.
Baxter International, one of the main suppliers of IV fluids in the U.S., announced on Sept. 29 that production at the site had been halted due to flooding. The company is currently collaborating with the government to assess the extent of the damage and work towards resuming operations at the plant.
As a result of the closure, the U.S. Food and Drug Administration has reported shortages of Baxter's Dextrose solutions for low blood sugar and a saline solution. Additionally, there are concerns about Hurricane Milton further disrupting the IV fluid supply chain, prompting efforts to relocate products away from the storm's projected path.
In response to the crisis, Baxter has outlined plans to restart production in phases and aims to restore 90% to 100% allocation of certain IV solutions by the end of 2024. The company has also increased the allocation of its highest demand IV fluids for direct customers and distributors, effective Oct. 9.
Meanwhile, Fresenius, a German healthcare company, has announced plans to expedite the launch of new infusion-solution production lines at a North Carolina facility to help alleviate potential shortages. The U.S. health department is also collaborating with other domestic IV solutions manufacturers to address the supply crunch.
In conclusion, the closure of Baxter International's North Carolina facility and the subsequent shortage of IV fluids could have significant implications for the healthcare industry and patients in need of critical medical treatments. It is crucial for healthcare providers and stakeholders to monitor the situation closely and take necessary steps to mitigate the impact of these disruptions on patient care.